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Background
Contrast enhanced magnetic resonance angiography
(MRA) is generally performed during a long breath-hold
(BH), limiting its use in infants and children. Time
resolved MR angiography (TRA) often use data sharing
techniques, making it is necessary to acquire data during
a BH. This study proposes a high-resolution free breath-
ing (FB) TRA sequence for use in adults and children
with congenital heart disease (CHD).
Methods
A TRA sequence was developed by combining spiral tra-
jectories with sensitivity encoding (SENSE, x4 kx-ky and
x2 kz) and partial Fourier (75% kz). Total acceleration
was 10.7x and enabled acquisition of a high resolution
volume (2.3x2.3x2.3mm) every 1.3s with no data sharing.
Importantly, this allowed data to be acquired during FB.
Conventional BH-MRA and FB-TRA data was acquired
in 45 patients with CHD.
Diagnostic accuracy was assessed by 2 evaluators. The
diagnosis were compared to those in the clinical CMR
report (assessed from the whole CMR examination,
including 3D whole heart and selected cine, black blood
and flow imaging).
Vessel diameter measurements were made in all
patients, at 6 positions; sinotubular junction (Ao1),
proximal descending aorta (Ao2), descending aorta at
the diaphragm (Ao3), main pulmonary artery (MPA),
mid left pulmonary artery (LPA), and mid right pulmon-
ary artery (RPA).
Additionally, we calculated quantitative image quality
for both sequences at Ao1 and MPA, using measures of
signal-to-noise ratio (SNR), contrast-to-noise ratio
(CNR), relative contrast (RC) and edge sharpness.
Results
The median age of the patients was 23.1±15.7years
(range: 8-80 years, 13 of whom were <18 years old). FB-
TRA data was successfully acquired using in all 45
patients.
BH-MRA provided overall diagnostic accuracy of 82%,
and FB-TRA of 87%, with no statistical difference
between the 2 sequences (P=0.77). The specific ability of
the sequences to assess stenosis (N=13) found sensitiv-
ities of 62% and 69% for BH-MRA and FB-TRA, respec-
tively (P=0.56), with both having a specificity of 100%.
The specific ability of the sequences to assess dilation
(N=53) found sensitivities of 98% and 100% for BH-
MRA and FB-TRA, respectively (P=0.32), with both hav-
ing a specificity of 100%.
Vessel diameters measurements (table 1) made in 234
vessel segments showed excellent agreement between
the 2 techniques (r=0.98, P<0.05), with no bias (0.0mm,
P=0.71), and clinically acceptable limits of agreement
(-2.7 to +2.8mm).
Example images are shown in figure 1. BH-MRA had
significantly higher SNR (P<0.0001), CNR (P<0.0001)
and RC (P=0.02) compared to the FB-TRA images.
However, edge sharpness was significantly (P<0.0001)
higher in FB-TRA compared to BH-MRA.
Conclusions
We have described a FB-TRA technique that has been
shown to enable accurate diagnosis and vessel measures
compared to conventional BH-MRA. This technique
simplifies the MRA technique by eliminating the need
for bolus timing, and will enable angiography to be
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Table 1 Vessel diameter measurements from the two angiography sequences
Vessel N BH-MRA (mm) FB-TRA (mm) Bias* (mm) Limits of agreement* (mm) Correlation coefficient* (r) P-value*
Ao1 43 29 ± 6 (range: 21 to 46) 29 ± 6 (range: 19 to 47) -0.2 -2.7 to 2.3 0.98 P=0.40
Ao2 43 21 ± 5 (range: 14 to 38) 21 ± 6 (range: 14 to 40) 0.4 -3.0 to 3.7 0.96 P=0.18
Ao3 43 19 ± 4 (range: 13 to 32) 19 ± 4 (range: 14 to 34) 0.4 -2.0 to 2.7 0.96 P=0.06
MPA 35 29 ± 7 (range: 17 to 47) 29 ± 7 (range: 16 to 46) 0.1 -2.9 to 3.0 0.98 P=0.82
RPA 35 22 ± 6 (range: 13 to 35) 21 ± 5 (range: 13 to 34) -0.3 -3.1 to 2.5 0.97 P=0.24
LPA 35 20 ± 5 (range: 8 to 31) 20 ± 5 (range: 8 to 31) -0.3 -2.5 to 2.0 0.98 P=0.14
Total 234 23 ± 7 (range: 8 to 47) 23 ± 7 (range: 8 to 47) 0.0 -2.7 to 2.8 0.98 P=0.71
* Calculated with BH-MRA sequence
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